Many studies have shown that the abnormal expression of FZD2 is significantly associated with the development of many tumors, such as gastric cancer 12, hepatocellular carcinoma 13 and endometrial cancer 14, in which FZD2 plays oncogenic roles. Here, FZD2 is linked to hepatocellular carcinoma.